Protagonist Therapeutics, Inc. (PTGX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$145.72-2.07%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · PTGX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||
| Revenues | — | 46.0 | 434.4 | 60.0 | 26.6 | 27.4 | 28.6 | — | 30.9 | — | — |
| Operating Expenses & Income | |||||||||||
| R&D Expenses | 175.2 | 159.3 | 138.1 | 120.2 | 126.2 | 126.0 | 74.5 | 65.0 | 59.5 | 46.2 | 25.7 |
| Operating Income | 58.3 | (158.1) | 252.8 | (93.7) | (131.4) | (125.8) | (64.5) | (80.5) | (42.3) | (37.9) | (32.7) |
| Earnings from Continuing Operations | |||||||||||
| Interest Expense | — | — | — | — | — | — | 0.6 | 0.2 | — | — | — |
| Interest & Investment Income | 26.1 | 28.8 | 26.3 | 14.9 | 4.1 | 0.4 | 0.9 | 2.8 | 2.6 | 0.9 | 0.2 |
| Net Interest Expenses | — | — | — | — | — | — | (0.3) | (2.6) | — | — | — |
| EBT, Incl. Unusual Items | 84.3 | (129.3) | 279.4 | (79.0) | (127.4) | (125.6) | (64.8) | (77.9) | (39.7) | (37.0) | — |
| Income Tax Expense | — | 0.8 | 4.2 | 0.0 | 0.0 | 0.0 | 1.3 | (0.7) | (0.8) | 0.0 | 0.0 |
| Net Income | |||||||||||
| Net Income | 82.9 | (130.1) | 275.2 | (79.0) | (127.4) | (125.6) | (66.2) | (77.2) | (38.9) | (37.0) | (37.2) |
| Per Share | |||||||||||
| Basic EPS | 1.26 | (2.05) | 4.47 | (1.39) | (2.60) | (2.71) | (1.92) | — | — | — | — |
| Diluted EPS | 1.17 | (2.05) | 4.23 | (1.39) | (2.60) | (2.71) | (1.92) | — | — | — | — |
| Basic Weighted Avg Shares | 65.9 | 63.6 | 61.6 | 56.8 | 49.0 | 46.3 | 34.4 | — | — | — | — |
| Diluted Weighted Avg Shares | 71.0 | 63.6 | 65.1 | 56.8 | 49.0 | 46.3 | 34.4 | — | — | — | — |
| Supplemental | |||||||||||
| EBITDA | — | (156.8) | 253.7 | (92.7) | (130.3) | (125.0) | (63.6) | (79.8) | (41.7) | (37.5) | (32.3) |
| EBIT | 58.3 | (158.1) | 252.8 | (93.7) | (131.4) | (125.8) | (64.5) | (80.5) | (42.3) | (37.9) | (32.7) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | -2.0% | 0.9% | 2.0% | 0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.